Work

Peripheral blood profiling of azacitidine's hypomethylation: Advancing precision medicine in juvenile chronic myelomonocytic leukaemia

Year: 2025
Type: article
Abstract: COMMENTARY ON: Schönung et al. Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacytidine therapy in juvenile myelomonocytic leukemia: Results of the EWOG-MESRAT study. Br J Haematol 2025; 207:1271-1278.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4415018774
FWCI:
Cites: 9
Cited by:
Related to: